Your Cancer Care is too Important to Wait

Providing Exceptional Care and Fostering a Safe Environment for Patients
Rutgers Cancer Institute of New Jersey

Newswise — New Brunswick, N.J., June 1, 2020 –Minimizing your exposure to COVID-19 doesn’t require sacrificing cancer care or preventive services. As New Jersey’s only NCI-designated Comprehensive Cancer Center and the state’s leading authority on cancer, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are taking extra precautions to provide the safest environment possible for patients, visitors, and staff.

Several guidelines for reducing the spread of the virus have been implemented at our facilities across the state to ensure that patients can continue to receive exceptional care close to home.

These include screening for COVID-19 symptoms upon entry, following strict social distancing measures, prohibiting most visitors, enhancing already rigorous cleaning and disinfecting practices, and mandating a mask or face covering for all patients and staff.

If you are due for a routine cancer screening, don’t delay scheduling an appointment. Postponement of appointments like cancer screenings could result in delayed diagnosis and treatment.

If you have a symptom that concerns you, speak to your primary care physician or oncologist.  Examination of symptoms will allow your physician to address any issues early on when treatment may be more successful.

If you are in the middle of cancer treatment or scheduled to begin soon, you should talk with your oncologist about the risks of delaying therapy. In many cases, the benefits of treatment outweigh the risks of contracting the virus, however, this decision is individualized.

Your cancer care can’t wait. Schedule a consultation or a follow-up appointment with one of our cancer specialists by calling 844-CANCERNJ (844-226-2376) or visit  In-person clinic visits as well as telemedicine appointments are available.

Andrew M. Evens, DO, MSc, FACP, is the Associate Director for Clinical Services and Director of the Lymphoma Program, Rutgers Cancer Institute; and Medical Director of Oncology Services, RWJBarnabas Health.

Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.

Showing results

110 of 2454